Novo A/S as of Dec. 31, 2015
Portfolio Holdings for Novo A/S
Novo A/S holds 14 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ophthotech | 37.1 | $386M | 4.9M | 78.53 | |
| Vanguard Total Stock Market ETF (VTI) | 29.9 | $311M | 3.0M | 104.30 | |
| Inogen (INGN) | 13.7 | $142M | 3.5M | 40.09 | |
| Vanguard European ETF (VGK) | 10.1 | $105M | 2.1M | 49.88 | |
| Colucid Pharmaceuticals | 2.5 | $26M | 3.1M | 8.37 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 2.4 | $25M | 2.5M | 10.05 | |
| Penumbra (PEN) | 1.2 | $13M | 236k | 53.81 | |
| Nabriva Therapeutics | 0.8 | $8.4M | 875k | 9.62 | |
| Invuity | 0.8 | $8.2M | 925k | 8.82 | |
| Htg Molecular Diagnostics | 0.5 | $5.6M | 1.3M | 4.36 | |
| Wright Med Group Inc right 03/01/2019 | 0.5 | $4.7M | 4.6M | 1.02 | |
| Tokai Pharmaceuticals | 0.4 | $4.1M | 471k | 8.72 | |
| Glaukos (GKOS) | 0.2 | $1.9M | 75k | 24.69 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.0M | 128k | 8.04 |
